BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Maslennikov R, Ivashkin V, Efremova I, Poluektova E, Kudryavtseva A, Krasnov G. Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis. World J Gastroenterol 2022; 28(10): 1067-1077 [PMID: 35431497 DOI: 10.3748/wjg.v28.i10.1067]
URL: https://www.wjgnet.com/1007-9327/full/v28/i10/1067.htm
Number Citing Articles
Irina Efremova, Roman Maslennikov, Elena Poluektova, Ekaterina Vasilieva, Yury Zharikov, Andrey Suslov, Yana Letyagina, Evgenii Kozlov, Anna Levshina, Vladimir Ivashkin. Epidemiology of small intestinal bacterial overgrowthWorld Journal of Gastroenterology 2023; 29(22): 3400-3421 doi: 10.3748/wjg.v29.i22.3400
Ya-Nan Li, Na-Ling Kang, Jia-Ji Jiang, Yue-Yong Zhu, Yu-Rui Liu, Da-Wu Zeng, Fei Wang. Gut microbiota of hepatitis B virus-infected patients in the immune-tolerant and immune-active phases and their implications in metabolite changesWorld Journal of Gastroenterology 2022; 28(35): 5188-5202 doi: 10.3748/wjg.v28.i35.5188
Irina Efremova, Roman Maslennikov, Aliya Alieva, Elena Poluektova, Vladimir Ivashkin. Small Intestinal Bacterial Overgrowth Is Associated with Poor Prognosis in CirrhosisMicroorganisms 2023; 11(4): 1017 doi: 10.3390/microorganisms11041017
Qi-Qi Xie, Jia-Feng Wang, Yang-Fen Zhang, Dong-Hui Xu, Bo Zhou, Ting-Hui Li, Zhi-Peng Li. Glucose substrate in the hydrogen breath test for gut microbiota determination: A recommended noninvasive testWorld Journal of Clinical Cases 2022; 10(26): 9536-9538 doi: 10.12998/wjcc.v10.i26.9536
Shiqi Zhang, Pinglan Li, Suwon Lee, Yu Wang, Chunming Tan, Nan Shang. Weizmannia coagulans: an Ideal Probiotic for Gut Health Food Science and Human Wellness 2023; : 1 doi: 10.26599/FSHW.2022.9250002
D.V. Garbuzenko. Gut microbiota modulation in acute decompensation of liver cirrhosis: theory and therapeutic potentialDokazatel'naya gastroenterologiya 2022; 11(4): 65 doi: 10.17116/dokgastro20221104165
Aneta Kiecka, Marian Szczepanik. Proton pump inhibitor-induced gut dysbiosis and immunomodulation: current knowledge and potential restoration by probioticsPharmacological Reports 2023; 75(4): 791 doi: 10.1007/s43440-023-00489-x
Yu. N. Alekhin, V. S. Ponamarev, O. S. Popova. Pathogenetic bases of the combined use of drugs from the groups of hepatoprotectors and phytosorbentsInternational Journal of Veterinary Medicine 2022; (2): 47 doi: 10.52419/issn2072-2419.2022.2.47
Roman Maslennikov, Aliya Alieva, Elena Poluektova, Yury Zharikov, Andrey Suslov, Yana Letyagina, Ekaterina Vasileva, Anna Levshina, Evgenii Kozlov, Vladimir Ivashkin. Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiotaWorld Journal of Gastroenterology 2023; 29(27): 4236-4251 doi: 10.3748/wjg.v29.i27.4236
Dmitry Victorovich Garbuzenko. Therapeutic possibilities of gut microbiota modulation in acute decompensation of liver cirrhosisWorld Journal of Hepatology 2023; 15(4): 525-537 doi: 10.4254/wjh.v15.i4.525